Cargando…
Reference Gene Validation for RT–qPCR in PBMCs from Asthmatic Patients with or without Obesity
Obesity is known to impair the efficacy of glucocorticoid medications for asthma control. Glucocorticoid-induced gene expression studies may be useful to discriminate those obese asthmatic patients who present a poor response to glucocorticoids. The expression of genes of interest is normalized with...
Autores principales: | Bantulà, Marina, Arismendi, Ebymar, Picado, César, Mullol, Joaquim, Roca-Ferrer, Jordi, Tubita, Valeria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149987/ https://www.ncbi.nlm.nih.gov/pubmed/35645343 http://dx.doi.org/10.3390/mps5030035 |
Ejemplares similares
-
Differences in Inflammatory Cytokine Profile in Obesity-Associated Asthma: Effects of Weight Loss
por: Bantulà, Marina, et al.
Publicado: (2022) -
Asthma and Obesity: Two Diseases on the Rise and Bridged by Inflammation
por: Bantulà, Marina, et al.
Publicado: (2021) -
Effect of Obesity on the Expression of Genes Associated with Severe Asthma—A Pilot Study
por: Bantulà, Marina, et al.
Publicado: (2023) -
Effects of Obesity and Asthma on Lung Function and Airway Dysanapsis in Adults and Children
por: Arismendi, Ebymar, et al.
Publicado: (2020) -
A high-throughput screening RT-qPCR assay for quantifying surrogate markers of immunity from PBMCs
por: Browne, Daniel J., et al.
Publicado: (2022)